Clinical significance of IgA nephropathy with hyperuricemia
As one of the most common primary glomerulopathies, immunoglobulin A nephropathy(IgAN) is a major cause of end-stage renal disease (ESRD). Its proper treatment has remained rather challenging. Disease progression may be delayed if associated risk factors are intervened. Hyperuricemia is a common cli...
Saved in:
Main Authors: | Han Zhou (Author), Wei Liang (Author), Guo-hua Ding (Author) |
---|---|
Format: | Book |
Published: |
Editorial Department of Journal of Clinical Nephrology,
2024-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical Significance of Galactose-Deficient IgA1 by KM55 in Patients with IgA Nephropathy
by: Kai Zhang, et al.
Published: (2019) -
Clinicopathological Characteristics, Role of Immunosuppressive Therapy and Progression in IgA Nephropathy with Hyperuricemia
by: Yiping Ruan, et al.
Published: (2018) -
The Clinical Significance and Potential Role of Cathepsin S in IgA Nephropathy
by: Jingying Zhao, et al.
Published: (2021) -
Correlation between serum Klotho and uromodulin expression levels and IgA nephropathy complicated with hyperuricemia
by: Di Wei, et al.
Published: (2024) -
The Clinical Significance of Uric Acid and Complement Activation in the Progression of IgA Nephropathy
by: Yasar Caliskan, et al.
Published: (2016)